Cargando…
Cellular immune response to hepatitis-C-virus in subjects without viremia or seroconversion: is it important?
Hepatitis C Virus (HCV) causes chronic infection and represents a global health burden. To date, there is no licensed vaccine for HCV. The high viral replication rate and the existence of several HCV genotypes and quasispecies hamper the development of an effective universal vaccine. In this regard,...
Autor principal: | Abdelwahab, Sayed F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4867533/ https://www.ncbi.nlm.nih.gov/pubmed/27186234 http://dx.doi.org/10.1186/s13027-016-0070-0 |
Ejemplares similares
-
Frequent Transient Hepatitis C viremia without Seroconversion among Healthcare Workers in Cairo, Egypt
por: Munier, Aline, et al.
Publicado: (2013) -
Hepatitis C virus RNA viremia in Central Africa.
por: Cancré, N, et al.
Publicado: (1999) -
Intrafamilial Exposure to SARS-CoV-2 Associated with Cellular Immune Response without Seroconversion, France
por: Gallais, Floriane, et al.
Publicado: (2021) -
Hepatitis C Virus-Specific Cell-Mediated Immune Responses in Children Born to Mothers Infected with Hepatitis C Virus
por: El-Kamary, Samer S., et al.
Publicado: (2013) -
Association of blood groups with hepatitis C viremia
por: Mahnoor, et al.
Publicado: (2021)